Literature DB >> 24936567

Utility of Adrenocorticotropic Hormone in Assessing the Response to Transsphenoidal Surgery for Cushing's Disease.

Patricia M Salmon1, Pooja D Loftus2, Robert L Dodd3, Griffith Harsh3, Olivia S Chu3, Laurence Katznelson4.   

Abstract

OBJECTIVES: To compare adrenocorticotrophic hormone (ACTH) and cortisol dynamics in subjects with Cushing's disease (CD) following transsphenoidal surgery (TSS) and to determine the value of early postoperative ACTH levels in predicting subsequent hypocortisolemia.
METHODS: Following TSS for CD, serum cortisol and plasma ACTH were measured every 6 hours in the absence of empiric glucocorticoid coverage.
RESULTS: A total of 26 subjects (25 female) underwent 28 operations. Hypocortisolemia was achieved in 21 (81%) subjects after the initial TSS. Repeat TSS was performed in 2 subjects, resulting in hypocortisolemia in 1. Subjects who achieved hypocortisolemia had significantly lower ACTH levels by 19 hours postoperatively (P = .007). Plasma ACTH fell to <30 pg/mL in 86% and <20 pg/mL in 82% of subjects who subsequently achieved hypocortisolemia. Plasma ACTH declined to <30 pg/mL by a mean of 10 hours and to <20 pg/mL by 13 hours prior to hypocortisolemia. Follow-up data were available on 25 patients for a median of 23 months. Three subjects who achieved initial surgical remission had disease recurrence at 19, 24, and 36 months; all of these subjects had a postoperative nadir serum cortisol levels <3 μg/dL and plasma ACTH <20 pg/mL.
CONCLUSION: Following TSS for CD, plasma ACTH declined prior to achievement of hypocortisolemia in most subjects. In the majority, the ACTH level reached a nadir of <20 pg/mL. Low early postoperative ACTH levels predict early hypocortisolemia but may not accurately predict long-term remission.

Entities:  

Year:  2014        PMID: 24936567     DOI: 10.4158/EP14140.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  4 in total

1.  Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.

Authors:  Yana Stolyarov; James Mirocha; Adam N Mamelak; Anat Ben-Shlomo
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

Review 2.  Approach to the postoperative patient with Cushing's disease.

Authors:  Martin J Rutkowski; Jonathan D Breshears; Sandeep Kunwar; Manish K Aghi; Lewis S Blevins
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 3.  Variability in laboratory parameters used for management of Cushing's syndrome.

Authors:  Francesca Pecori Giraldi; Alberto G Ambrogio
Journal:  Endocrine       Date:  2015-07-10       Impact factor: 3.633

4.  Prognostic usefulness of ACTH in the postoperative period of Cushing's disease.

Authors:  Pablo Abellán-Galiana; Carmen Fajardo-Montañana; Pedro Riesgo-Suárez; Marcelino Pérez-Bermejo; Celia Ríos-Pérez; José Gómez-Vela
Journal:  Endocr Connect       Date:  2019-09       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.